Genetic Predisposition to Liking Amphetamine Reduces Risk of Schizophrenia and ADHD
University of Chicago Medical CenterGenetic variants associated with enjoying the effects of d-amphetamine—the active ingredient in Adderall—are also associated with a reduced risk for developing schizophrenia and attention deficit hyperactivity disorder (ADHD), report scientists from the University of Chicago .